Table 2 Univariate analysis
NRM | PRM | Severe pulmonary complication a | ARDS | |||||
---|---|---|---|---|---|---|---|---|
% | P-value | % | P-value | % | P-value | % | P-value | |
DRI: low risk+intermediate vs high risk+very−high risk | 14.4 (7.4–23.4) vs 9.4 (2.3–22.6) | 0.25 | 5.8 (1.8–13.1) vs 3.1 (0.2–14.2) | 0.56 | 25.9 (16.2–36.7) vs 25.0 (11.5–41.1) | 0.55 | 10.1 (4.4–18.5) vs 3.1 (0.2–14.2) | 0.16 |
Disease: lymphoid vs myeloid | 19.8 (8.6–34.4) vs 9.0 (3.6–17.3) | 0.04 | 11.4 (3.5–24.4) vs 1.5 (0.1–7.2) | 0.02 | 39.7 (23.5–55.5) vs 17.9 (9.8–28.0) | 0.03 | 14.2 (5.1–27.8) vs 4.5 (1.2–11.4) | 0.04 |
HCT-CI: 0 vs ⩾1 | 8.3 (2.1–20.2) vs 15.2 (7.7–24.9) | 0.14 | 0.0 (0.0–0.0) vs 7.6 (2.8–15.6) | 0.09 | 21.7 (10.0–36.3) vs 27.3 (17.1–38.4) | 0.39 | 2.7 (0.2–12.3) vs 10.6 (4.6–19.5) | 0.11 |
Previous pulmonary event: no vs yes | 9.4 (3.8–18.1) vs 18.4 (8.0–32.4) | 0.5 | 3.1 (0.6–9.8) vs 7.9 (2.0–19.4) | 0.28 | 21.8 (12.6–32.6) vs 31.6 (17.5–46.7) | 0.28 | 3.1 (0.06–0.09) vs 15.8 (6.3–29.2) | <0.01 |
Age: < vs ⩾ median (58 years) | 15.6 (7.2–26.9) vs 9.8 (3.6–19.9) | 0.57 | 3.9 (0.7–12.0) vs 5.9 (1.5–14.8) | 0.65 | 26.8 (15.5–39.3) vs 24.0 (13.2–36.6) | 0.94 | 7.6 (2.4–16.8) vs 8.0 (2.5–17.7) | 0.76 |
Conditioning regimen: RIC vs MAC | 10.7 (5.2–18.4) vs 22.2 (6.6–43.6) | 0.11 | 5.9 (2.2–12.5) vs 0.0 (0.0–0.0) | 0.29 | 24.9 (16.2–34.6) vs 278 (9.6–49.6) | 0.97 | 5.9 (2.2–12.5) vs 16.7 (3.9–37.2) | 0.18 |
Use of ATG: yes vs no | 9.5 (4.4–16.9) vs 27.8 (9.7–49.5) | 0.12 | 3.6 (0.9–9.3) vs 11.1 (1.7–30.5) | 0.18 | 23.7 (15.2–33.2) vs 33.3 (13.0–55.3) | 0.52 | 5.9 (2.2–12.4) vs 16.7 (3.9–37.3) | 0.18 |
LFS: 2 vs ⩾3 | 12.7 (5.1–23.9) vs 12.7 (5.5–23.0) | 0.79 | 4.3 (0.8–13.0) vs 5.5 (1.4–13.8) | 0.76 | 19 (9.3–31.3) vs 30.9 (0.2–0.4) | 0.06 | 6.4 (1.6–15.8) vs 9.1 (3.3–18.5) | 0.40 |
DLCO10s % of predicted normal value: >80% vs 60–80% vs <60% | 12.7 (5.1–23.9) vs 12.8 (5.1–24.1) vs 12.5 (0.4–45.3) | 0.95 | 4.3 (0.8–13.0) vs 4.3 (0.8– 13.0) vs 12.5 (0.4–45.3) | 0.57 | 19.0 (9.3–31.3) vs 27.7 (15.7–41.0) vs 50.0 (12.2–79.6) | 0.06 | 6.4 (1.6–15.8) vs 6.4 (1.6–15.9) vs 25.0 (3.0–57.9) | 0.20 |
DLNO % of predicted normal value: >80% vs 60–80% vs <60% | 18.2 (8.4–30.9) vs 8.0 (2.5–17.7) vs 11.1 (0.5–40.9) | 0.26 | 9.1 (2.8–19.9) vs 0.0 (0.0–0.0) vs 11.1 (0.5–40.9) | 0.07 | 20.5 (10.0–33.5) vs 24.0 (13.2–36.6) vs 59.3 (13.0–87.4) | 0.02 | 9.1 (2.8–19.9) vs 2.0 (0.2–9.3) vs 35.6 (5.7–68.8) | <0.005 |
HR | P-value | HR | P-value | HR | P-value | HR | P-value | |
DLCO10s % of predicted normal valueb | 1.0 (1.0–1.1) | 0.94 | 1.0 (0.9–1.0) | 0.23 | 1.0 (0.9–1.0) | 0.04 | 1.0 (0.9–1.0) | 0.13 |
DLNO % of predicted normal valueb | 1.0 (0.9–1.0) | 0.35 | 1.0 (0.9–1.1) | 0.45 | 2.0 (1.1–3.7) | 0.02 | 1.0 (0.9–1.0) | 0.17 |
DLNO/DLCO ratiob | 0.9 (0.5–1.6) | 0.7 | 1.6 (1.0–2.6) | 0.04 | 0.9 (0.5–1.7) | 0.78 | 1.6 (0.6–4.0) | 0.34 |